Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity
Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer–drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the...
Saved in:
Published in | Archives of Toxicology Vol. 89; no. 1; pp. 57 - 72 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Science and Business Media LLC
01.01.2015
Springer Berlin Heidelberg Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer–drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR,
NR1I2
) and constitutive androstane receptor (CAR,
NR1I3
). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes,
CYP3A4
and
CYP2B6
, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs. |
---|---|
AbstractList | Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs. Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs.[PUBLICATION ABSTRACT] Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer–drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2 ) and constitutive androstane receptor (CAR, NR1I3 ). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6 , respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs. Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs.Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs. |
Author | Ching Hao Cheng Miki Nakajima Yun-Ping Lim Shih Yu Chang Tsuyoshi Yokoi Jih Jung Chen Cing Yu Chen Dong-Zong Hung Wei Cheng Chen Wei Chih Ma Yu Hsien Lin Chao-Jung Chen Lei Wan |
Author_xml | – sequence: 1 givenname: Yun-Ping surname: Lim fullname: Lim, Yun-Ping email: limyp@mail2000.com.tw, limyp@mail.cmu.edu.tw organization: Department of Pharmacy, College of Pharmacy, China Medical University, Department of Emergency, Toxicology Center, China Medical University Hospital – sequence: 2 givenname: Ching-Hao surname: Cheng fullname: Cheng, Ching-Hao organization: Department of Pharmacy, College of Pharmacy, China Medical University, Department of Pharmacy, Changhua Show Chwan Memorial Hospital – sequence: 3 givenname: Wei-Cheng surname: Chen fullname: Chen, Wei-Cheng organization: Department of Pharmacy, College of Pharmacy, China Medical University – sequence: 4 givenname: Shih-Yu surname: Chang fullname: Chang, Shih-Yu organization: Department of Public Health, Chung Shan Medical University – sequence: 5 givenname: Dong-Zong surname: Hung fullname: Hung, Dong-Zong organization: Department of Pharmacy, College of Pharmacy, China Medical University, Department of Emergency, Toxicology Center, China Medical University Hospital – sequence: 6 givenname: Jih-Jung surname: Chen fullname: Chen, Jih-Jung organization: Graduate Institute of Pharmaceutical Technology, Tajen University – sequence: 7 givenname: Lei surname: Wan fullname: Wan, Lei organization: School of Chinese Medicine, China Medical University – sequence: 8 givenname: Wei-Chih surname: Ma fullname: Ma, Wei-Chih organization: Department of Pharmacy, College of Pharmacy, China Medical University – sequence: 9 givenname: Yu-Hsien surname: Lin fullname: Lin, Yu-Hsien organization: Department of Pharmacy, College of Pharmacy, China Medical University – sequence: 10 givenname: Cing-Yu surname: Chen fullname: Chen, Cing-Yu organization: Department of Pharmacy, College of Pharmacy, China Medical University – sequence: 11 givenname: Tsuyoshi surname: Yokoi fullname: Yokoi, Tsuyoshi organization: Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University – sequence: 12 givenname: Miki surname: Nakajima fullname: Nakajima, Miki organization: Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University – sequence: 13 givenname: Chao-Jung surname: Chen fullname: Chen, Chao-Jung email: cjchen@mail.cmu.edu.tw, ironmanchen@yahoo.com.tw organization: Graduate Institute of Integrated Medicine, China Medical University, Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital |
BackLink | https://cir.nii.ac.jp/crid/1871709543061240320$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/25069801$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkstuEzEUhkeoiKaFB2CDRoJFuhg4vo3tZRRRqFQJhIrUneV4nMTVxA62ByXvxsPVk7QCdVGxsWX7-3-f21l14oO3VfUWwUcEwD8lAAy0AUQbhAk0uxfVBFGCG-BEnFQTIBQaxlt0Wp2ldAeAsJDkVXWKGbRSAJpUf2Z9v-9rl0Jeu2D22uts6-ns6mZ-UTu_dguXU72NduW1t_VtHa2x2xxiPf1---Oi1r6rTfApuzxk99uOFzGkPMJ_0flsRE0BdHbBH1TbGLI1xVyvtCsG5d1mvXE-bNfWNwemHEOnY8m6cb4bjC2f7XPIYeeMy_vX1cul7pN987CfVz8vP9_MvzbX375czWfXjWEcciMlkgsiDV5qoxGTgiNsRMcXeikEwYtOC9ZibgmjXUtb0Umq2dJKLSzDmHNyXk2PviXmX4NNWW1cMrbvS5ZhSAq1lJdOAEP_g-IWJGJQ0PdP0LswRF8SGSnEkWgxLdS7B2pYbGynttFtdNyrxxYWgB8BU-qeol2qUppDmXPUrlcI1Dgs6jgsqgyLGodF7YoSPVE-mj-nwUdNKqxf2fhP0M-IPhxF3rkS3bii0gQOklECLcIUCAZyD8oO3Og |
CitedBy_id | crossref_primary_10_1007_s11101_022_09809_0 crossref_primary_10_1021_acs_jafc_8b03372 crossref_primary_10_1080_10408398_2021_1995322 crossref_primary_10_1089_adt_2017_809 crossref_primary_10_1016_j_toxlet_2015_02_012 crossref_primary_10_1080_10408444_2016_1223014 crossref_primary_10_1016_j_ejmech_2015_12_018 crossref_primary_10_1007_s00418_023_02255_9 crossref_primary_10_1016_j_taap_2023_116770 crossref_primary_10_1080_15376516_2017_1333555 crossref_primary_10_1007_s00228_016_2095_0 crossref_primary_10_1021_acs_jafc_7b02696 crossref_primary_10_1074_jbc_M117_815217 crossref_primary_10_1007_s13738_019_01832_x crossref_primary_10_1146_annurev_pharmtox_010617_052429 crossref_primary_10_3389_fnut_2021_748433 crossref_primary_10_1007_s00204_017_1948_3 crossref_primary_10_1007_s10555_022_10068_w crossref_primary_10_1002_hep_30028 crossref_primary_10_1016_j_mce_2019_02_002 crossref_primary_10_1016_j_phymed_2017_09_016 crossref_primary_10_1021_acs_jafc_8b04116 crossref_primary_10_1517_17425255_2015_1043887 |
Cites_doi | 10.1101/gad.846800 10.1021/tx700079z 10.1073/pnas.95.21.12208 10.1146/annurev.pharmtox.43.100901.135754 10.1210/er.2001-0038 10.1074/jbc.274.10.6043 10.1007/s00280-011-1815-5 10.1016/S0278-6915(97)00103-8 10.1093/toxsci/kfh286 10.1080/00498250210128675 10.1172/JCI41514 10.1016/j.tiv.2009.11.020 10.1016/j.biomed.2012.08.002 10.1021/jf021116c 10.2174/138920008785821710 10.1073/pnas.81.5.1327 10.1124/mol.106.029264 10.1124/dmd.31.5.620 10.1016/j.cbi.2010.01.008 10.1021/bi0268753 10.2174/138920007779815995 10.1093/carcin/23.6.1009 10.1159/000136531 10.1016/j.bcp.2012.01.030 10.1124/jpet.104.072785 10.1007/s00204-012-0902-7 10.1172/JCI3703 10.1093/carcin/21.6.1175 10.1111/j.1582-4934.2011.01367.x 10.1158/1078-0432.CCR-06-1592 10.1207/S15327914NC441_7 10.1126/science.1073502 10.1016/j.tox.2011.03.015 10.1016/S0300-483X(98)00085-7 10.1124/dmd.31.12.1499 10.1124/mol.106.023796 10.1016/j.ejphar.2006.12.040 10.1038/87912 10.1093/carcin/bgg023 10.1016/j.taap.2005.03.015 10.1136/gut.26.1.26 10.1124/jpet.110.168294 10.1002/mnfr.200900323 10.1016/j.cbi.2006.12.003 10.2174/187231210791698483 10.1016/j.addr.2010.07.008 10.1016/j.tips.2012.07.003 10.2133/dmpk.DMPK-11-RG-126 10.1124/jpet.109.159210 10.1056/NEJM198702193160807 10.1016/j.bcp.2011.08.023 10.1016/j.taap.2006.12.013 10.1016/S0168-1605(03)00297-6 10.1124/dmd.109.028654 10.1124/dmd.109.027565 10.1210/me.2007-0218 10.1021/tx600260a 10.1210/mend.16.5.0828 10.1016/j.ejps.2004.10.015 10.1124/dmd.107.019547 10.3390/md10010242 10.1016/j.addr.2010.07.002 10.1016/j.tips.2012.03.003 10.1124/jpet.106.107573 10.1016/S0168-1605(00)00343-3 10.1111/j.2042-7158.1982.tb04692.x 10.1073/pnas.051551698 10.1172/JCI21867 10.1016/S0026-895X(24)12603-X 10.1124/mol.56.6.1329 10.1128/MCB.19.9.6318 10.1016/S0090-9556(25)07393-3 |
ContentType | Journal Article |
Copyright | Springer-Verlag Berlin Heidelberg 2014 Springer-Verlag Berlin Heidelberg 2015 |
Copyright_xml | – notice: Springer-Verlag Berlin Heidelberg 2014 – notice: Springer-Verlag Berlin Heidelberg 2015 |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7U7 7X7 7XB 88E 88I 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA ATCPS AZQEC BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. M0S M1P M2O M2P MBDVC PATMY PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PYCSY Q9U 7X8 |
DOI | 10.1007/s00204-014-1230-x |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Toxicology Abstracts ProQuest Health & Medical Collection (NC LIVE) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Science Database Research Library (Corporate) Environmental Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Environmental Science Collection ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection ProQuest Research Library Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Toxicology Abstracts Research Library Prep MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1432-0738 |
EndPage | 72 |
ExternalDocumentID | 3543828061 25069801 10_1007_s00204_014_1230_x |
Genre | Research Support, Non-U.S. Gov't Journal Article Feature |
GroupedDBID | --- .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 36B 4.4 406 408 409 40D 40E 4P2 5RE 5VS 67N 67Z 6NX 78A 7X7 7XC 88E 88I 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHIR ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFGCZ AFHIU AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ATCPS ATHPR AXYYD AYFIA AZFZN AZQEC B-. BA0 BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CCPQU CSCUP DDRTE DL5 DNIVK DPUIP DWQXO EBD EBLON EBS EDH EIOEI EJD EMB EMOBN EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GUQSH GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2O M2P M4Y MA- N2Q N9A NB0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PATMY PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 PT5 PYCSY Q2X QOK QOR QOS R89 R9I RHV RNS ROL RPX RRX RSU RSV RYH S16 S27 S3A S3B SAP SBL SBY SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZMTXR ZOVNA ~EX ~KM -4W -56 -5G -BR -EM -Y2 -~C .55 .GJ .HR 2.D 28- 2P1 2VQ 3O- 3SX 3V. 53G 5QI AARHV ADINQ ADYPR AEFIE AFEXP AGGDS AHAVH BBWZM CAG COF EN4 GQ6 KOW NDZJH OVD RIG RNI RZK S1Z S26 S28 SCLPG T16 TEORI WK6 X7M Z5O Z7U Z7V Z7W Z7Y Z7Z Z82 Z83 Z85 Z86 Z87 Z8O Z8P Z8Q Z8S Z8T Z8V Z8W Z8Z Z91 ZGI AAYXX ADHKG AFOHR AGQPQ CITATION CGR CUY CVF ECM EIF NPM 7T2 7TK 7U7 7XB 8FK ABRTQ C1K K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c570t-9919b39c2faca1598712c8d7baf8832bda85627e354d6468d94a5fe9a8e522773 |
IEDL.DBID | U2A |
ISSN | 0340-5761 1432-0738 |
IngestDate | Fri Jul 11 00:26:15 EDT 2025 Tue Aug 05 11:14:11 EDT 2025 Sat Jul 26 02:18:18 EDT 2025 Thu Apr 03 07:08:23 EDT 2025 Tue Jul 01 05:04:14 EDT 2025 Thu Apr 24 23:04:06 EDT 2025 Fri Feb 21 02:32:56 EST 2025 Thu Jun 26 21:26:43 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Inducer–drug interaction Drug-induced cytotoxicity Pregnane X receptor Allyl isothiocyanate Constitutive androstane receptor Cytochrome P450 3A4 Cytochrome P450 2B6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c570t-9919b39c2faca1598712c8d7baf8832bda85627e354d6468d94a5fe9a8e522773 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3239-2817 0000-0002-9525-3232 0000-0003-3834-9243 |
PMID | 25069801 |
PQID | 1641718624 |
PQPubID | 60277 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_1647020051 proquest_miscellaneous_1642609150 proquest_journals_1641718624 pubmed_primary_25069801 crossref_citationtrail_10_1007_s00204_014_1230_x crossref_primary_10_1007_s00204_014_1230_x springer_journals_10_1007_s00204_014_1230_x nii_cinii_1871709543061240320 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Archives of Toxicology |
PublicationTitleAbbrev | Arch Toxicol |
PublicationTitleAlternate | Arch Toxicol |
PublicationYear | 2015 |
Publisher | Springer Science and Business Media LLC Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Science and Business Media LLC – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Cheng, Ma, Krausz, Idle, Gonzalez (CR11) 2009; 37 Rodriguez-Antona, Donato, Boobis, Edwards, Watts, Castell, Gomez-Lechon (CR54) 2002; 32 Beckett, Chapman, Dyson, Hayes (CR3) 1985; 26 Synold, Dussault, Forman (CR60) 2001; 7 Jacobs, Nolan, Hood (CR30) 2005; 209 Munday, Munday (CR48) 2002; 44 Wang, Faucette, Gilbert, Jolley, Sueyoshi, Negishi, LeCluyse (CR66) 2003; 31 Reimers, Jezek (CR52) 1971; 25 McCarthy, Pollak, Hanniman, Sinal (CR45) 2004; 311 Moore, Maglich, McKee, Wisely, Willson, Kliewer, Lambert, Moore (CR46) 2002; 16 Hu, Yang, Chen, Cao, Chan, Duan, Huang, Yu, Wen, Zhou (CR28) 2007; 8 Shin, Masuda, Naohide (CR56) 2004; 94 Lim, Ma, Liu, Lin, Hu, Chen, Hung, Hsieh, Huang (CR39) 2012; 2012 Xie, Barwick, Simon, Pierce, Safe, Blumberg, Guzelian, Evans (CR72) 2000; 14 Zhang (CR76) 2010; 54 (CR15) 2010; 8 Rigalli, Ruiz, Perdomo, Villanueva, Mottino, Catania (CR53) 2011; 285 Takezawa, Matsunaga, Aikawa, Nakamura, Ohmori (CR61) 2012; 27 Itoh, Nakajima, Higashi, Yoshida, Nagata, Yamazoe, Yokoi (CR29) 2006; 319 Staudinger, Goodwin, Jones, Hawkins-Brown, MacKenzie, LaTour, Liu, Klaassen, Brown, Reinhard, Willson, Koller, Kliewer (CR57) 2001; 98 Guillouzo, Corlu, Aninat, Glaise, Morel, Guguen-Guillouzo (CR22) 2007; 168 Mason (CR43) 1987; 316 Gao, Xie (CR17) 2012; 33 Hancock (CR25) 1992; 8 Lehmann, McKee, Watson, Willson, Moore, Kliewer (CR38) 1998; 102 Sueyoshi, Kawamoto, Zelko, Honkakoski, Negishi (CR58) 1999; 274 Xiao, Srivastava, Lew, Zeng, Hershberger, Johnson, Trump, Singh (CR71) 2003; 24 Krausova, Stejskalova, Wang, Vrzal, Dvorak, Mani, Pavek (CR35) 2011; 82 Yun, Okerholm, Guengerich (CR73) 1993; 21 Wang, Venkatesh, Li, Goetz, Mukherjee, Biswas, Zhu, Kaubisch, Wang, Pullman, Whitney, Kuro-O, Roig, Shay, Mohammadi, Mani (CR69) 2011; 121 Potter, Thorgeirsson, Jollow, Mitchell (CR51) 1974; 12 Guengerich, MacDonald (CR21) 2007; 20 Ha, Bigler, Wendt, Maggiorini, Follath (CR24) 2005; 24 James, Mayeux, Hinson (CR31) 2003; 31 Pascussi, Robert, Nguyen, Walrant-Debray, Garabedian, Martin, Pineau, Saric, Navarro, Maurel, Vilarem (CR50) 2005; 115 Zhou, Poulton, Grun, Bammler, Blumberg, Thummel, Eaton (CR79) 2007; 71 Cheng, Shah, Gonzalez (CR12) 2012; 33 Wagner, Boesch-Saadatmandi, Dose, Schultheiss, Rimbach (CR63) 2012; 16 Moya, Gomez-Lechon, Castell, Jover (CR47) 2010; 184 Liu, Lim, Hu (CR40) 2012; 10 Conney (CR13) 2003; 43 Kostrubsky, Szakacs, Jeffery, Woods, Bement, Wrighton, Sinclair, Sinclair (CR34) 1997; 27 Wang, Tompkins (CR65) 2008; 9 Sultana, Porter, Savage, McNeil (CR59) 2003; 51 Boelsterli, Lim (CR5) 2007; 220 Goodwin, Moore, Stoltz, McKee, Kliewer (CR19) 2001; 60 Schulman (CR55) 2010; 62 Wang, Li, Moore, Johnson, Maglich, Goodwin, Ittoop, Wisely, Creech, Parks, Collins, Willson, Kalpana, Venkatesh, Cho, Xie, Roboz, Redinbo, Moore, Mani (CR68) 2008; 22 Bollard, Stribbling, Mitchell, Caldwell (CR6) 1997; 35 Dahlin, Miwa, Lu, Nelson (CR14) 1984; 81 Healan-Greenberg, Waring, Kempf, Blomme, Tirona, Kim (CR26) 2008; 36 Bauer, Yang, Hartz, Olson, Zhao, Kalvass, Pollack, Miller (CR2) 2006; 70 Lake, Renwick, Cunninghame, Price, Surry, Evans (CR37) 1998; 131 Goodwin, Hodgson, Liddle (CR18) 1999; 56 Ahlin, Hilgendorf, Karlsson, Szigyarto, Uhlén, Artursson (CR1) 2009; 37 Walko, Combest, Spasojevic, Yu, Bhushan, Hull, Hoskins, Armstrong, Carey, Collicio, Dees (CR64) 2012; 69 Kliewer, Goodwin, Willson (CR33) 2002; 23 Matsuda, Ochi, Nagatomo, Yoshikawa (CR44) 2007; 561 Wang, Huang, Li, Teotico, Sinz, Baker, Staudinger, Kalpana, Redinbo, Mani (CR67) 2007; 13 Chen, Tang, Guo, Wang, Boral, Nie (CR10) 2012; 83 Chen, Tang, Robbins, Nie (CR9) 2010; 334 Flanagan, Storey, Holt, Farmer (CR16) 1982; 34 Kawamoto, Sueyoshi, Zelko, Moore, Washburn, Negishi (CR32) 1999; 19 Zhang, Talalay (CR77) 1998; 58 Chen (CR7) 2010; 62 Mahamuni, Khose, Menaa, Badole (CR42) 2012; 2 Guo, Moffit, Nicol, Ward, Aleksunes, Slitt, Kliewer, Manautou, Gonzalez (CR23) 2004; 82 Nielsen, Rios (CR49) 2000; 60 Zhang, Huang, Chua, Wei, Moore (CR78) 2002; 298 CR62 Watkins, Maglich, Moore, Wisely, Noble, Davis-Searles, Lambert, Kliewer, Redinbo (CR70) 2003; 42 Krul, Humblot, Philippe, Vermeulen, van Nuenen, Havenaar, Rabot (CR36) 2002; 23 Hosomi, Akai, Minami, Yoshikawa, Fukami, Nakajima, Yokoi (CR27) 2010; 24 Lo, Lim, Chen, Hsu, Souček, Yun, Xie, Ueng (CR41) 2012; 86 Bertilsson, Heidrich, Svensson, Asman, Jendeberg, Sydow-Backman, Ohlsson, Postlind, Blomquist, Berkenstam (CR4) 1998; 95 Zhang (CR75) 2000; 21 Guengerich (CR20) 2008; 21 Zambon, Fontana, Kajbaf (CR74) 2010; 4 Chen, Tompkins, Li, Li, Kim, Zheng, Wang (CR8) 2010; 332 H Matsuda (1230_CR44) 2007; 561 WZ Potter (1230_CR51) 1974; 12 D Reimers (1230_CR52) 1971; 25 TC McCarthy (1230_CR45) 2004; 311 M Moya (1230_CR47) 2010; 184 JF Hancock (1230_CR25) 1992; 8 SA Kliewer (1230_CR33) 2002; 23 Y Zhang (1230_CR75) 2000; 21 B Goodwin (1230_CR18) 1999; 56 C Zhou (1230_CR79) 2007; 71 UA Boelsterli (1230_CR5) 2007; 220 D Xiao (1230_CR71) 2003; 24 G Ahlin (1230_CR1) 2009; 37 AE Wagner (1230_CR63) 2012; 16 AH Conney (1230_CR13) 2003; 43 M Itoh (1230_CR29) 2006; 319 IG Schulman (1230_CR55) 2010; 62 B Goodwin (1230_CR19) 2001; 60 T Kawamoto (1230_CR32) 1999; 19 BG Lake (1230_CR37) 1998; 131 T Sueyoshi (1230_CR58) 1999; 274 T Sultana (1230_CR59) 2003; 51 H Wang (1230_CR68) 2008; 22 A Guillouzo (1230_CR22) 2007; 168 H Wang (1230_CR67) 2007; 13 LP James (1230_CR31) 2003; 31 FP Guengerich (1230_CR21) 2007; 20 L Krausova (1230_CR35) 2011; 82 CH Yun (1230_CR73) 1993; 21 H Wang (1230_CR69) 2011; 121 EFSA (1230_CR15) 2010; 8 T Takezawa (1230_CR61) 2012; 27 Y Chen (1230_CR10) 2012; 83 JP Rigalli (1230_CR53) 2011; 285 JM Lehmann (1230_CR38) 1998; 102 JL Staudinger (1230_CR57) 2001; 98 J Cheng (1230_CR11) 2009; 37 FP Guengerich (1230_CR20) 2008; 21 CL Liu (1230_CR40) 2012; 10 JM Pascussi (1230_CR50) 2005; 115 J Gao (1230_CR17) 2012; 33 B Bauer (1230_CR2) 2006; 70 C Healan-Greenberg (1230_CR26) 2008; 36 HR Ha (1230_CR24) 2005; 24 M Bollard (1230_CR6) 1997; 35 J Cheng (1230_CR12) 2012; 33 ZP Hu (1230_CR28) 2007; 8 S Zambon (1230_CR74) 2010; 4 LB Moore (1230_CR46) 2002; 16 DC Dahlin (1230_CR14) 1984; 81 TW Synold (1230_CR60) 2001; 7 H Wang (1230_CR66) 2003; 31 Y Zhang (1230_CR77) 1998; 58 JW Mason (1230_CR43) 1987; 316 SP Mahamuni (1230_CR42) 2012; 2 MN Jacobs (1230_CR30) 2005; 209 C Krul (1230_CR36) 2002; 23 T Chen (1230_CR7) 2010; 62 RJ Flanagan (1230_CR16) 1982; 34 R Munday (1230_CR48) 2002; 44 H Wang (1230_CR65) 2008; 9 GL Guo (1230_CR23) 2004; 82 J Zhang (1230_CR78) 2002; 298 CM Walko (1230_CR64) 2012; 69 GJ Beckett (1230_CR3) 1985; 26 YP Lim (1230_CR39) 2012; 2012 PV Nielsen (1230_CR49) 2000; 60 WS Lo (1230_CR41) 2012; 86 G Bertilsson (1230_CR4) 1998; 95 T Chen (1230_CR8) 2010; 332 Y Chen (1230_CR9) 2010; 334 Y Zhang (1230_CR76) 2010; 54 H Hosomi (1230_CR27) 2010; 24 W Xie (1230_CR72) 2000; 14 IS Shin (1230_CR56) 2004; 94 1230_CR62 C Rodriguez-Antona (1230_CR54) 2002; 32 VE Kostrubsky (1230_CR34) 1997; 27 RE Watkins (1230_CR70) 2003; 42 |
References_xml | – volume: 14 start-page: 3014 year: 2000 end-page: 3023 ident: CR72 article-title: Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR publication-title: Genes Dev doi: 10.1101/gad.846800 – volume: 8 start-page: 1943 year: 2010 ident: CR15 article-title: Scientific Opinion on the safety of allyl isothiocyanate for the proposed uses as a food additive publication-title: EFSA J – volume: 8 start-page: 153 year: 1992 end-page: 158 ident: CR25 article-title: COS Cell Expression publication-title: Methods Mol Biol – volume: 21 start-page: 70 year: 2008 end-page: 83 ident: CR20 article-title: Cytochrome P450 and chemical toxicology publication-title: Chem Res Toxicol doi: 10.1021/tx700079z – volume: 95 start-page: 12208 year: 1998 end-page: 12213 ident: CR4 article-title: Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.21.12208 – volume: 43 start-page: 1 year: 2003 end-page: 30 ident: CR13 article-title: Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450 publication-title: Ann Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.43.100901.135754 – volume: 23 start-page: 687 year: 2002 end-page: 702 ident: CR33 article-title: The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism publication-title: Endocr Rev doi: 10.1210/er.2001-0038 – volume: 274 start-page: 6043 year: 1999 end-page: 6046 ident: CR58 article-title: The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene publication-title: J Biol Chem doi: 10.1074/jbc.274.10.6043 – volume: 69 start-page: 1189 year: 2012 end-page: 1196 ident: CR64 article-title: The effect of a prepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-011-1815-5 – volume: 35 start-page: 933 year: 1997 end-page: 943 ident: CR6 article-title: The disposition of allyl isothiocyanate in the rat and mouse publication-title: Food Chem Toxicol doi: 10.1016/S0278-6915(97)00103-8 – volume: 60 start-page: 427 year: 2001 end-page: 431 ident: CR19 article-title: Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor publication-title: Mol Pharmacol – volume: 82 start-page: 374 year: 2004 end-page: 380 ident: CR23 article-title: Enhanced acetaminophen toxicity by activation of the pregnane X receptor publication-title: Toxicol Sci doi: 10.1093/toxsci/kfh286 – volume: 32 start-page: 505 year: 2002 end-page: 520 ident: CR54 article-title: Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells publication-title: Xenobiotica doi: 10.1080/00498250210128675 – volume: 121 start-page: 3220 year: 2011 end-page: 3232 ident: CR69 article-title: Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice publication-title: J Clin Invest doi: 10.1172/JCI41514 – volume: 24 start-page: 1032 year: 2010 end-page: 1038 ident: CR27 article-title: An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells publication-title: Toxicol In Vitro doi: 10.1016/j.tiv.2009.11.020 – volume: 2 start-page: 137 year: 2012 end-page: 146 ident: CR42 article-title: Therapeutic approaches to drug targets in hyperlipidemia publication-title: BioMedicine doi: 10.1016/j.biomed.2012.08.002 – volume: 51 start-page: 3586 year: 2003 end-page: 3591 ident: CR59 article-title: Comparison of isothiocyanate yield from wasabi rhizome tissues grown in soil or water publication-title: J Agric Food Chem doi: 10.1021/jf021116c – volume: 9 start-page: 598 year: 2008 end-page: 610 ident: CR65 article-title: CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme publication-title: Curr Drug Metab doi: 10.2174/138920008785821710 – volume: 81 start-page: 1327 year: 1984 end-page: 1331 ident: CR14 article-title: N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.81.5.1327 – volume: 56 start-page: 1329 year: 1999 end-page: 1339 ident: CR18 article-title: The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module publication-title: Mol Pharmacol – volume: 71 start-page: 220 year: 2007 end-page: 229 ident: CR79 article-title: The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor publication-title: Mol Pharmacol doi: 10.1124/mol.106.029264 – volume: 31 start-page: 620 year: 2003 end-page: 630 ident: CR66 article-title: Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes publication-title: Drug Metab Dispos doi: 10.1124/dmd.31.5.620 – volume: 184 start-page: 376 year: 2010 end-page: 387 ident: CR47 article-title: Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2010.01.008 – volume: 42 start-page: 1430 year: 2003 end-page: 1438 ident: CR70 article-title: A crystal structure of human PXR in complex with the St John’s wort compound hyperforin publication-title: Biochemistry doi: 10.1021/bi0268753 – volume: 8 start-page: 157 year: 2007 end-page: 171 ident: CR28 article-title: A mechanistic study on altered pharmacokinetics of irinotecan by St John’s wort publication-title: Curr Drug Metab doi: 10.2174/138920007779815995 – volume: 23 start-page: 1009 year: 2002 end-page: 1016 ident: CR36 article-title: Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model publication-title: Carcinogenesis doi: 10.1093/carcin/23.6.1009 – volume: 12 start-page: 129 year: 1974 end-page: 143 ident: CR51 article-title: Acetaminophen induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters publication-title: Pharmacology doi: 10.1159/000136531 – volume: 83 start-page: 1112 year: 2012 end-page: 1126 ident: CR10 article-title: Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2012.01.030 – volume: 311 start-page: 864 year: 2004 end-page: 873 ident: CR45 article-title: Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator activated receptor alpha target gene activation publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.104.072785 – volume: 86 start-page: 1927 year: 2012 end-page: 1938 ident: CR41 article-title: A dual function of the furanocoumarin chalepensin in inhibiting Cyp2a and inducing Cyp2b in mice: the protein stabilization and receptor-mediated activation publication-title: Arch Toxicol doi: 10.1007/s00204-012-0902-7 – volume: 102 start-page: 1016 year: 1998 end-page: 1023 ident: CR38 article-title: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions publication-title: J Clin Invest doi: 10.1172/JCI3703 – volume: 21 start-page: 1175 year: 2000 end-page: 1182 ident: CR75 article-title: Role of glutathione in the accumulation of anticarcinogen icisothiocyanates and their glutathione conjugates by murine hepatoma cells publication-title: Carcinogenesis doi: 10.1093/carcin/21.6.1175 – volume: 27 start-page: 57 year: 1997 end-page: 62 ident: CR34 article-title: Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A publication-title: Ann Clin Lab Sci – volume: 16 start-page: 836 year: 2012 end-page: 843 ident: CR63 article-title: Anti-inflammatory potential of allyl isothiocyanate − role of Nrf2, NF-κB and microRNA-155 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2011.01367.x – volume: 13 start-page: 2488 year: 2007 end-page: 2495 ident: CR67 article-title: Activated pregnenolone X-receptor is a target for ketoconazole and its analogs publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-1592 – volume: 44 start-page: 52 year: 2002 end-page: 59 ident: CR48 article-title: Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables publication-title: Nutr Cancer doi: 10.1207/S15327914NC441_7 – volume: 298 start-page: 422 year: 2002 end-page: 424 ident: CR78 article-title: Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR publication-title: Science doi: 10.1126/science.1073502 – volume: 285 start-page: 18 year: 2011 end-page: 24 ident: CR53 article-title: Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells publication-title: Toxicology doi: 10.1016/j.tox.2011.03.015 – volume: 131 start-page: 9 year: 1998 end-page: 20 ident: CR37 article-title: Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver publication-title: Toxicology doi: 10.1016/S0300-483X(98)00085-7 – volume: 31 start-page: 1499 year: 2003 end-page: 1506 ident: CR31 article-title: Acetaminophen-induced hepatotoxicity publication-title: Drug Metab Dispos doi: 10.1124/dmd.31.12.1499 – volume: 70 start-page: 1212 year: 2006 end-page: 1219 ident: CR2 article-title: In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation publication-title: Mol Pharmacol doi: 10.1124/mol.106.023796 – volume: 19 start-page: 6318 year: 1999 end-page: 6322 ident: CR32 article-title: Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene publication-title: Mol Cell Biol – volume: 21 start-page: 403 year: 1993 end-page: 409 ident: CR73 article-title: Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation publication-title: Drug Metab Dispos – volume: 561 start-page: 172 year: 2007 end-page: 181 ident: CR44 article-title: Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.12.040 – volume: 7 start-page: 584 year: 2001 end-page: 590 ident: CR60 article-title: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux publication-title: Nat Med doi: 10.1038/87912 – volume: 24 start-page: 891 year: 2003 end-page: 897 ident: CR71 article-title: Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis publication-title: Carcinogenesis doi: 10.1093/carcin/bgg023 – volume: 209 start-page: 123 year: 2005 end-page: 133 ident: CR30 article-title: Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR) publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2005.03.015 – volume: 58 start-page: 4632 year: 1998 end-page: 4639 ident: CR77 article-title: Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes publication-title: Cancer Res – volume: 26 start-page: 26 year: 1985 end-page: 31 ident: CR3 article-title: Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage publication-title: Gut doi: 10.1136/gut.26.1.26 – volume: 334 start-page: 999 year: 2010 end-page: 1008 ident: CR9 article-title: Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.168294 – volume: 54 start-page: 127 year: 2010 end-page: 135 ident: CR76 article-title: Allyl isothiocyanate as a cancer chemopreventive phytochemical publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200900323 – volume: 168 start-page: 66 year: 2007 end-page: 73 ident: CR22 article-title: The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2006.12.003 – volume: 4 start-page: 120 year: 2010 end-page: 128 ident: CR74 article-title: Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis LC-MS/MS publication-title: Drug Metab Lett doi: 10.2174/187231210791698483 – volume: 62 start-page: 1257 year: 2010 end-page: 1264 ident: CR7 article-title: Overcoming drug resistance by regulating nuclear receptors publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.07.008 – volume: 33 start-page: 552 year: 2012 end-page: 558 ident: CR17 article-title: Targeting xenobiotic receptors PXR and CAR for metabolic diseases publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.07.003 – volume: 27 start-page: 430 year: 2012 end-page: 438 ident: CR61 article-title: Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells publication-title: Drug Metab Pharmacokinet doi: 10.2133/dmpk.DMPK-11-RG-126 – volume: 332 start-page: 106 year: 2010 end-page: 115 ident: CR8 article-title: A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.109.159210 – volume: 316 start-page: 455 year: 1987 end-page: 466 ident: CR43 article-title: Amiodarone publication-title: N Engl J Med doi: 10.1056/NEJM198702193160807 – volume: 25 start-page: 255 year: 1971 end-page: 262 ident: CR52 article-title: The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives publication-title: Prax Pneumol – volume: 82 start-page: 1180 year: 2011 end-page: 1771 ident: CR35 article-title: Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.08.023 – volume: 220 start-page: 92 year: 2007 end-page: 107 ident: CR5 article-title: Mitochondrial abnormalities—a link to idiosyncratic drug hepatotoxicity? publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2006.12.013 – volume: 94 start-page: 255 year: 2004 end-page: 261 ident: CR56 article-title: Bactericidal activity of wasabi (Wasabia japonica) against Helicobacter pylori publication-title: Int J Food Microbiol doi: 10.1016/S0168-1605(03)00297-6 – volume: 37 start-page: 2275 year: 2009 end-page: 2283 ident: CR1 article-title: Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.028654 – volume: 37 start-page: 1611 year: 2009 end-page: 1621 ident: CR11 article-title: Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.027565 – volume: 22 start-page: 838 year: 2008 end-page: 857 ident: CR68 article-title: The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor publication-title: Mol Endocrinol doi: 10.1210/me.2007-0218 – volume: 20 start-page: 344 year: 2007 end-page: 369 ident: CR21 article-title: Applying mechanisms of chemical toxicity to predict drug safety publication-title: Chem Res Toxicol doi: 10.1021/tx600260a – volume: 16 start-page: 977 year: 2002 end-page: 986 ident: CR46 article-title: Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors publication-title: Mol Endocrinol doi: 10.1210/mend.16.5.0828 – volume: 24 start-page: 271 year: 2005 end-page: 279 ident: CR24 article-title: Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2004.10.015 – volume: 2012 start-page: 242810 year: 2012 ident: CR39 article-title: Sesamin: a naturally occurring lignan inhibits CYP3A4 by antagonizing the pregnane X receptor activation publication-title: Evid Based Complement Alternat Med – volume: 36 start-page: 500 year: 2008 end-page: 507 ident: CR26 article-title: A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor publication-title: Drug Metab Dispos doi: 10.1124/dmd.107.019547 – volume: 10 start-page: 242 year: 2012 end-page: 257 ident: CR40 article-title: Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells publication-title: Mar Drugs doi: 10.3390/md10010242 – volume: 62 start-page: 1307 year: 2010 end-page: 1315 ident: CR55 article-title: Nuclear receptors as drug targets for metabolic disease publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.07.002 – volume: 33 start-page: 323 year: 2012 end-page: 330 ident: CR12 article-title: Pregnane X receptor as a target for treatment of inflammatory bowel disorders publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.03.003 – volume: 319 start-page: 693 year: 2006 end-page: 702 ident: CR29 article-title: Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1 alpha publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.107573 – volume: 60 start-page: 219 year: 2000 end-page: 229 ident: CR49 article-title: Inhibition of fungal growth on bread by volatile components from spices and herbs, and the possible application in active packaging, with special emphasis on mustard essential oil publication-title: Int J Food Microbiol doi: 10.1016/S0168-1605(00)00343-3 – volume: 34 start-page: 638 year: 1982 end-page: 643 ident: CR16 article-title: Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.1982.tb04692.x – ident: CR62 – volume: 98 start-page: 3369 year: 2001 end-page: 3374 ident: CR57 article-title: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.051551698 – volume: 115 start-page: 177 year: 2005 end-page: 186 ident: CR50 article-title: Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia publication-title: J Clin Invest doi: 10.1172/JCI21867 – volume: 26 start-page: 26 year: 1985 ident: 1230_CR3 publication-title: Gut doi: 10.1136/gut.26.1.26 – volume: 24 start-page: 891 year: 2003 ident: 1230_CR71 publication-title: Carcinogenesis doi: 10.1093/carcin/bgg023 – volume: 220 start-page: 92 year: 2007 ident: 1230_CR5 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2006.12.013 – volume: 316 start-page: 455 year: 1987 ident: 1230_CR43 publication-title: N Engl J Med doi: 10.1056/NEJM198702193160807 – volume: 60 start-page: 427 year: 2001 ident: 1230_CR19 publication-title: Mol Pharmacol doi: 10.1016/S0026-895X(24)12603-X – volume: 31 start-page: 620 year: 2003 ident: 1230_CR66 publication-title: Drug Metab Dispos doi: 10.1124/dmd.31.5.620 – volume: 69 start-page: 1189 year: 2012 ident: 1230_CR64 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-011-1815-5 – volume: 37 start-page: 2275 year: 2009 ident: 1230_CR1 publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.028654 – volume: 27 start-page: 57 year: 1997 ident: 1230_CR34 publication-title: Ann Clin Lab Sci – volume: 32 start-page: 505 year: 2002 ident: 1230_CR54 publication-title: Xenobiotica doi: 10.1080/00498250210128675 – volume: 34 start-page: 638 year: 1982 ident: 1230_CR16 publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.1982.tb04692.x – volume: 14 start-page: 3014 year: 2000 ident: 1230_CR72 publication-title: Genes Dev doi: 10.1101/gad.846800 – volume: 23 start-page: 1009 year: 2002 ident: 1230_CR36 publication-title: Carcinogenesis doi: 10.1093/carcin/23.6.1009 – volume: 21 start-page: 70 year: 2008 ident: 1230_CR20 publication-title: Chem Res Toxicol doi: 10.1021/tx700079z – volume: 33 start-page: 552 year: 2012 ident: 1230_CR17 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.07.003 – volume: 285 start-page: 18 year: 2011 ident: 1230_CR53 publication-title: Toxicology doi: 10.1016/j.tox.2011.03.015 – volume: 4 start-page: 120 year: 2010 ident: 1230_CR74 publication-title: Drug Metab Lett doi: 10.2174/187231210791698483 – volume: 58 start-page: 4632 year: 1998 ident: 1230_CR77 publication-title: Cancer Res – volume: 311 start-page: 864 year: 2004 ident: 1230_CR45 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.104.072785 – volume: 7 start-page: 584 year: 2001 ident: 1230_CR60 publication-title: Nat Med doi: 10.1038/87912 – volume: 184 start-page: 376 year: 2010 ident: 1230_CR47 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2010.01.008 – volume: 9 start-page: 598 year: 2008 ident: 1230_CR65 publication-title: Curr Drug Metab doi: 10.2174/138920008785821710 – volume: 82 start-page: 374 year: 2004 ident: 1230_CR23 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfh286 – volume: 56 start-page: 1329 year: 1999 ident: 1230_CR18 publication-title: Mol Pharmacol doi: 10.1124/mol.56.6.1329 – volume: 16 start-page: 977 year: 2002 ident: 1230_CR46 publication-title: Mol Endocrinol doi: 10.1210/mend.16.5.0828 – volume: 86 start-page: 1927 year: 2012 ident: 1230_CR41 publication-title: Arch Toxicol doi: 10.1007/s00204-012-0902-7 – volume: 44 start-page: 52 year: 2002 ident: 1230_CR48 publication-title: Nutr Cancer doi: 10.1207/S15327914NC441_7 – volume: 115 start-page: 177 year: 2005 ident: 1230_CR50 publication-title: J Clin Invest doi: 10.1172/JCI21867 – volume: 62 start-page: 1307 year: 2010 ident: 1230_CR55 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.07.002 – volume: 51 start-page: 3586 year: 2003 ident: 1230_CR59 publication-title: J Agric Food Chem doi: 10.1021/jf021116c – volume: 62 start-page: 1257 year: 2010 ident: 1230_CR7 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.07.008 – volume: 31 start-page: 1499 year: 2003 ident: 1230_CR31 publication-title: Drug Metab Dispos doi: 10.1124/dmd.31.12.1499 – volume: 19 start-page: 6318 year: 1999 ident: 1230_CR32 publication-title: Mol Cell Biol doi: 10.1128/MCB.19.9.6318 – volume: 25 start-page: 255 year: 1971 ident: 1230_CR52 publication-title: Prax Pneumol – volume: 70 start-page: 1212 year: 2006 ident: 1230_CR2 publication-title: Mol Pharmacol doi: 10.1124/mol.106.023796 – volume: 81 start-page: 1327 year: 1984 ident: 1230_CR14 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.81.5.1327 – volume: 21 start-page: 1175 year: 2000 ident: 1230_CR75 publication-title: Carcinogenesis doi: 10.1093/carcin/21.6.1175 – volume: 334 start-page: 999 year: 2010 ident: 1230_CR9 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.168294 – volume: 24 start-page: 1032 year: 2010 ident: 1230_CR27 publication-title: Toxicol In Vitro doi: 10.1016/j.tiv.2009.11.020 – volume: 8 start-page: 157 year: 2007 ident: 1230_CR28 publication-title: Curr Drug Metab doi: 10.2174/138920007779815995 – volume: 22 start-page: 838 year: 2008 ident: 1230_CR68 publication-title: Mol Endocrinol doi: 10.1210/me.2007-0218 – volume: 332 start-page: 106 year: 2010 ident: 1230_CR8 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.109.159210 – volume: 42 start-page: 1430 year: 2003 ident: 1230_CR70 publication-title: Biochemistry doi: 10.1021/bi0268753 – volume: 21 start-page: 403 year: 1993 ident: 1230_CR73 publication-title: Drug Metab Dispos doi: 10.1016/S0090-9556(25)07393-3 – volume: 274 start-page: 6043 year: 1999 ident: 1230_CR58 publication-title: J Biol Chem doi: 10.1074/jbc.274.10.6043 – volume: 561 start-page: 172 year: 2007 ident: 1230_CR44 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.12.040 – volume: 82 start-page: 1180 year: 2011 ident: 1230_CR35 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.08.023 – volume: 36 start-page: 500 year: 2008 ident: 1230_CR26 publication-title: Drug Metab Dispos doi: 10.1124/dmd.107.019547 – volume: 54 start-page: 127 year: 2010 ident: 1230_CR76 publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200900323 – volume: 319 start-page: 693 year: 2006 ident: 1230_CR29 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.107573 – ident: 1230_CR62 – volume: 2012 start-page: 242810 year: 2012 ident: 1230_CR39 publication-title: Evid Based Complement Alternat Med – volume: 131 start-page: 9 year: 1998 ident: 1230_CR37 publication-title: Toxicology doi: 10.1016/S0300-483X(98)00085-7 – volume: 60 start-page: 219 year: 2000 ident: 1230_CR49 publication-title: Int J Food Microbiol doi: 10.1016/S0168-1605(00)00343-3 – volume: 121 start-page: 3220 year: 2011 ident: 1230_CR69 publication-title: J Clin Invest doi: 10.1172/JCI41514 – volume: 8 start-page: 1943 year: 2010 ident: 1230_CR15 publication-title: EFSA J – volume: 102 start-page: 1016 year: 1998 ident: 1230_CR38 publication-title: J Clin Invest doi: 10.1172/JCI3703 – volume: 8 start-page: 153 year: 1992 ident: 1230_CR25 publication-title: Methods Mol Biol – volume: 168 start-page: 66 year: 2007 ident: 1230_CR22 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2006.12.003 – volume: 24 start-page: 271 year: 2005 ident: 1230_CR24 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2004.10.015 – volume: 209 start-page: 123 year: 2005 ident: 1230_CR30 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2005.03.015 – volume: 71 start-page: 220 year: 2007 ident: 1230_CR79 publication-title: Mol Pharmacol doi: 10.1124/mol.106.029264 – volume: 20 start-page: 344 year: 2007 ident: 1230_CR21 publication-title: Chem Res Toxicol doi: 10.1021/tx600260a – volume: 23 start-page: 687 year: 2002 ident: 1230_CR33 publication-title: Endocr Rev doi: 10.1210/er.2001-0038 – volume: 98 start-page: 3369 year: 2001 ident: 1230_CR57 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.051551698 – volume: 12 start-page: 129 year: 1974 ident: 1230_CR51 publication-title: Pharmacology doi: 10.1159/000136531 – volume: 95 start-page: 12208 year: 1998 ident: 1230_CR4 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.21.12208 – volume: 35 start-page: 933 year: 1997 ident: 1230_CR6 publication-title: Food Chem Toxicol doi: 10.1016/S0278-6915(97)00103-8 – volume: 13 start-page: 2488 year: 2007 ident: 1230_CR67 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-1592 – volume: 94 start-page: 255 year: 2004 ident: 1230_CR56 publication-title: Int J Food Microbiol doi: 10.1016/S0168-1605(03)00297-6 – volume: 37 start-page: 1611 year: 2009 ident: 1230_CR11 publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.027565 – volume: 10 start-page: 242 year: 2012 ident: 1230_CR40 publication-title: Mar Drugs doi: 10.3390/md10010242 – volume: 83 start-page: 1112 year: 2012 ident: 1230_CR10 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2012.01.030 – volume: 43 start-page: 1 year: 2003 ident: 1230_CR13 publication-title: Ann Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.43.100901.135754 – volume: 33 start-page: 323 year: 2012 ident: 1230_CR12 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.03.003 – volume: 16 start-page: 836 year: 2012 ident: 1230_CR63 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2011.01367.x – volume: 27 start-page: 430 year: 2012 ident: 1230_CR61 publication-title: Drug Metab Pharmacokinet doi: 10.2133/dmpk.DMPK-11-RG-126 – volume: 2 start-page: 137 year: 2012 ident: 1230_CR42 publication-title: BioMedicine doi: 10.1016/j.biomed.2012.08.002 – volume: 298 start-page: 422 year: 2002 ident: 1230_CR78 publication-title: Science doi: 10.1126/science.1073502 |
SSID | ssj0012893 ssib006157733 ssib021655073 ssib002808830 ssib025126965 ssib000577016 ssib022236507 ssib000950934 ssib020539858 ssib058492304 |
Score | 2.2259798 |
Snippet | Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer–drug interactions and improving... Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving... |
SourceID | proquest pubmed crossref springer nii |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 57 |
SubjectTerms | Acetaminophen Acetaminophen - metabolism Acetaminophen - toxicity Amiodarone Amiodarone - metabolism Amiodarone - toxicity Animals Biomedical and Life Sciences Biomedicine Blotting, Western Cell Differentiation Cell Differentiation - drug effects Cell Line, Tumor Cell Survival Cell Survival - drug effects Constitutive Androstane Receptor Cytochrome P-450 CYP2B6 Cytochrome P-450 CYP2B6 - genetics Cytochrome P-450 CYP2B6 - metabolism Cytochrome P-450 CYP3A Cytochrome P-450 CYP3A - genetics Cytochrome P-450 CYP3A - metabolism Cytotoxicity Drug therapy Environmental Health Gene Expression Regulation, Enzymologic Gene Expression Regulation, Enzymologic - drug effects Humans Isothiocyanates Isothiocyanates - pharmacology Mice Molecular Toxicology Neurons Occupational Medicine/Industrial Medicine Pharmacology/Toxicology Pregnane X Receptor Receptors, Cytoplasmic and Nuclear Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors Receptors, Cytoplasmic and Nuclear - genetics Receptors, Steroid Receptors, Steroid - antagonists & inhibitors Receptors, Steroid - genetics Reverse Transcriptase Polymerase Chain Reaction Transcriptional Activation Transfection |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection (NC LIVE) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_e-SKI-G3PO4ngw50STJu0aZ9kWTxOQRG5g30rSZreBdZ03fZg93-7P85J-nGKui8L3U7alJlMfzOZ_gahN4moc6kyRuIcwlVesJoUmiqS5jmjdV1xEUr-v3zNzi7450W6GBJu7VBWOfrE4KirRvsc-XuA9TH40SzhH1Y_ie8a5XdXhxYae-iupy7zVi0WU8AFrrcn3WWcEsDV8birSQOJaBLqLzxrH6Nk88d7ac9Z-y_I-dd2aXgLnT5EDwb4iGe9vh-hO8Y9Rvf73BvuPyl6gm5my-V2iW0LWrCN3koHgBIfzz6dz0-wdVdW2a7Fq7W5dNIZvMDg9cwKgm98_G3x_QRLV2HdDFUE4A39H_7jEC98KzqfeVE9tkcLowbWhxbLS2nhAnDedPKHdZ69wJEgA4dNJdeNM8S6CiwLbrbtmq7ZWA0hwVN0cfrxfH5Ghi4NRKeCdgQAZqFYoZNaagngCCKwROeVULIGfSeqkjlgLGFYyquMZ3lVcOkr3GRuAPsJwZ6hfQf3fIFwTQUM5UZRLTkTpoCwv1Y1E4qLGmwtQnTUUakHCnPfSWNZTuTLQa0lqLX0ai03EXo7DVn1_B27hI9A8XBp_xvDgwgAoJx5FMh9o_kIHY4mUQ5LvS1vDTNCr6fTsEj9zgsoprkOMhA3FgC-d8oI6nN8cYSe9-Y2zRhwalYAlojQu9H-fpvA_x7nYPd0X6J7gP7SPp90iPa79bU5AoTVqVdhGf0CWbEgpA priority: 102 providerName: ProQuest |
Title | Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity |
URI | https://cir.nii.ac.jp/crid/1871709543061240320 https://link.springer.com/article/10.1007/s00204-014-1230-x https://www.ncbi.nlm.nih.gov/pubmed/25069801 https://www.proquest.com/docview/1641718624 https://www.proquest.com/docview/1642609150 https://www.proquest.com/docview/1647020051 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbY9oKEEHcCW2UkHjZQpFycOHkMVccAMU3TKpWnyHGczVJxqjaT1v_Gj-NzboAYk3hJlebYuZxj-zs-N0LeBrxKRBGHrp9AXWVpWLmp9Ao3SpLQq6qS8dbl_-tpfDJnnxfRoo_j3gze7oNJsp2px2C3No4Tqq_Nsxd6LoDjXgTV3fpxzYNsNB1Ag-hqIjPPBZj2B1PmbV38sRjtGK1vw5l_2Ujbpef4EXnYY0aadUx-TO4p84Q86DbcaBdH9JT8yJbL7ZLqDT69ruVWGKBIeph9upgeUW2udKGbDV2t1aURRtEFxVSnVtC46eHZ4vyIClNSWfeuA5gC7R82IsQS_yKdZpZUDjXR2lZ9qocNFZdCowNcV434ro1NWWDclgandSnWtVGuNiXECTfbNnVT32gJPeAZmR_PLqYnbl-awZUR9xoXqDItwlQGlZACiAhqVyCTkheiApODohQJgBVXYcTKmMVJmTJh3dpEogD4OA-fk12De74ktPI4mjJVeFKwkKsUun5VVCEvGK8gYA7xBh7lss9bbstnLPMx43LL1hxszS1b8xuHvBubrLqkHXcRH4Dx6NoefbwIB-pkoYV-zFaXd8j-IBJ5P743OZRMH6t6HDCHvBkvY2RacwsYU1-3NFAWUyDuO2m4Zzf2fIe86MRtfGKA0zgFgHDI-0H-fnuAf73Oq_-ifk3uAwFG3Z7SPtlt1tfqACirKSZkhy84jsnUn5C97OO3LzP8fpidnp1P2hH3E7DQImc |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe28QDShPgmsIGRQNpAFmnsxMkDQlVhatmHEOqkvmW242yWilPaTLT_FH8BfxznfA0E9G0vkRKfP6I7n39nn-8QehnwPBYyoqQXg7nKEpqTRPmShHFM_TzPGK9c_o9PouEp-zQJJxvoR3sXxrlVtjqxUtRZodwe-VuA9T3Qo1HA3s--EZc1yp2utik0arE41KvvYLIt3o0-AH9fBcHBx_FgSJqsAkSF3C8JAKJE0kQFuVACFnOwGAIVZ1yKHMYXyEzEgAm4piHLIhbFWcKE88gSsQaswjmFdjfRDUZharqb6YPOpQRUfR3klzKfAI7vtaeofhW0NKj8PVyUQOqT5R_r4KY15l8Q96_j2WrVO7iDbjdwFfdr-bqLNrS9h7brvT5cX2G6j372p9PVFJsFcN0UaiUsAFi81x-NB_vY2AsjTbnAs7k-t8JqPMGgZfUMjH2893nyZR8Lm2FVNF4LoH3dB3cZxRFfkQ76jlS16diqWk2UiQUW58JAA1CuS_HVWBctwZKKBl6LTMwLq4mxGUgydLYqi7JYGgUmyAN0ei38e4i2LPT5GOHc51CVaekrwSjXiZZBLnPKJeM5yLaH_JZHqWpCprvMHdO0C_ZcsTUFtqaOrenSQ6-7KrM6Xsg64l1gPDTtnj34EQ6Al1GHOplLbO-hnVYk0ka1LNKrieChF10xKAV30gOMKS4rGrBTEwD7a2m47_YUex56VItbN2LAxVEC2MVDb1r5-20A__udJ-uH-xzdHI6Pj9Kj0cnhU3QLkGdY72XtoK1yfql3Ad2V8lk1pTA6u-45_AtnaFyr |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe2ISEkhPgmsIGRQNpA1pLYjZMHhKqOamUwTWiT-hZsxx6WilPaTLT_GuKP45yPDgT0bS-RkpwdR_fh39nnO4RexNykQiaURCm4qyyjhmQqlKSXpjQ0pmC8Dvn_eJwcnrH34954A_3ozsL4sMrOJtaGuiiVXyPfB1gfgR1NYrZv2rCIk4Ph2-k34itI-Z3WrpxGIyJHevkd3Lf5m9EB8PplHA_fnQ4OSVthgKgeDysC4CiTNFOxEUrAxA7eQ6zSgkthYKyxLEQK-IBr2mNFwpK0yJjw0Vki1YBbOKfQ7ya6xilPvY6lg1V4CZj9JuEvZSEBTB91O6phncA0rmM_fMZAGpLFH3PiprP2X3D3r63aegYc3ka3WuiK-42s3UEb2t1FN5t1P9wcZ7qHfvYnk-UE2zlIgC3VUjgAs3i3Pzod7GHrvlhpqzmezvS5E07jMQaLq6fg-OPdk_GnPSxcgVXZRjCAJfYP_MEUT3xJOuh7UtWVZqtbtRkn5licCwsdwHtdia_W-cwJjtQ0cFsWYlY6TawrQKrhY8uqrMqFVeCO3EdnV8K_B2jLwTcfIWxCDk2ZlqESjHKdaRkbaSiXjBuQ8wCFHY9y1aZP91U8Jvkq8XPN1hzYmnu25osAvVo1mTa5Q9YR7wDjoWt_jeBHOIBfRj0CZb7IfYC2O5HIWzMzzy-VIkDPV6_BQPhdH2BMeVHTgM-aAfBfS8NDv74YBehhI26rEQNGTjLAMQF63cnfbwP43-88Xj_cZ-g6aG_-YXR89ATdABDaa5a1ttFWNbvQOwD0Kvm01iiMPl-1Cv8C6bxg4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Allyl+isothiocyanate+%28AITC%29+inhibits+pregnane+X+receptor+%28PXR%29+and+constitutive+androstane+receptor+%28CAR%29+activation+and+protects+against+acetaminophen-+and+amiodarone-induced+cytotoxicity&rft.jtitle=Archives+of+toxicology&rft.au=Lim%2C+Yun-Ping&rft.au=Cheng%2C+Ching-Hao&rft.au=Chen%2C+Wei-Cheng&rft.au=Chang%2C+Shih-Yu&rft.date=2015-01-01&rft.issn=0340-5761&rft.eissn=1432-0738&rft.volume=89&rft.issue=1&rft.spage=57&rft.epage=72&rft_id=info:doi/10.1007%2Fs00204-014-1230-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00204_014_1230_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5761&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5761&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5761&client=summon |